docetaxel anhydrous has been researched along with exudates in 3 studies
Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (exudates) | Trials (exudates) | Recent Studies (post-2010) (exudates) |
---|---|---|---|---|---|
12,110 | 3,216 | 6,920 | 18,030 | 500 | 9,619 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fan, L; Goh, BC; Guo, JY; Hor, SY; Lee, HS; Lee, SC; Lim, RC; Lim, YW; Tan, T; Wang, LZ; Wong, CI | 1 |
Bustam, AZ; Ng, CH; Phua, CE; Saad, M; Taib, NA; Teh, YC; Yip, CH; Yusof, MM | 1 |
Annuar, MABA; Ho, GF; Jabir, RS; Stanslas, J | 1 |
1 trial(s) available for docetaxel anhydrous and exudates
Article | Year |
---|---|
PXR, CAR and HNF4alpha genotypes and their association with pharmacokinetics and pharmacodynamics of docetaxel and doxorubicin in Asian patients.
Topics: 5' Untranslated Regions; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asian People; Blood Platelets; Breast Neoplasms; China; Constitutive Androstane Receptor; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Docetaxel; Doxorubicin; Exons; Female; Gene Expression Regulation, Neoplastic; Gene Frequency; Genotype; Hepatocyte Nuclear Factor 4; Humans; India; Malaysia; Middle Aged; Neutropenia; Polymorphism, Genetic; Pregnane X Receptor; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Singapore; Taxoids; Time Factors; Transcription Factors; Treatment Outcome | 2008 |
2 other study(ies) available for docetaxel anhydrous and exudates
Article | Year |
---|---|
Risk of treatment related death and febrile neutropaenia with taxane-based adjuvant chemotherapy for breast cancer in a middle income country outside a clinical trial setting.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Carboplatin; Cause of Death; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Doxorubicin; Epirubicin; Female; Fever; Fluorouracil; Humans; Malaysia; Middle Aged; Neutropenia; Paclitaxel; Retrospective Studies; Risk Factors; Taxoids | 2012 |
Plasma alpha-1-acid glycoprotein as a potential predictive biomarker for non-haematological adverse events of docetaxel in breast cancer patients.
Topics: Antineoplastic Agents; Biomarkers; Breast Neoplasms; China; Docetaxel; Drug-Related Side Effects and Adverse Reactions; Exanthema; Female; Humans; India; Malaysia; Orosomucoid; Predictive Value of Tests; Prognosis; Stomatitis; Taxoids | 2018 |